Nucleoside triphosphate transporter and uses thereof

US10696720B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696720-B2
Application numberUS-201916546100-A
CountryUS
Kind codeB2
Filing dateAug 20, 2019
Priority dateJun 24, 2016
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum . Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of increasing production of a nucleic acid molecule in an E. coli cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8, (b) incubating the cell with one or more unnatural nucleoside triphosphates, and (c) transporting the one or more unnatural nucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base selected from the group consisting of 2. The method of claim 1 , wherein the nucleic acid molecule comprises DNA. 3. The method of claim 1 , wherein the nucleic acid molecule comprises RNA. 4. The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 5. The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 6. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from the group consisting of 7. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 8. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 9. A method of increasing production of a DNA nucleic acid molecule in an E. coli cell comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence comprising selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8, (b) incubating the cell with one or more unnatural 2′-deoxyribonucleoside triphosphates, and (c) transporting the one or more unnatural 2′-deoxyribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprise a base selected from the group consisting of: 10. A method of increasing production of a RNA nucleic acid molecule in an E. coli cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8, (b) incubating the cell with one or more unnatural ribonucleoside triphosphates, and (c) transporting the one or more unnatural ribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural ribonucleoside triphosphates comprise a base selected from the group consisting of: 11. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 12. The method of claim 11 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from 13. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 14. The method of claim 13 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from 15. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 16. The method of claim 15 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from 17. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 18. The method of claim 17 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from 19. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 20. The method of claim 19 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from 21. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 22. The method of claim 21 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from 23. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4. 24. The method of claim 23 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from 25. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6. 26. The method of claim 25 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from 27. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8. 28. The method of claim 27 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from

Assignees

Inventors

Classifications

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title

  • Stable introduction of foreign DNA into chromosome · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696720B2 cover?
Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum . Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transpor…
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07K14/405. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).